Ortin Laboratories Limited ORTINLAB.NS Stock
Ortin Laboratories Limited Price Chart
Ortin Laboratories Limited ORTINLAB.NS Financial and Trading Overview
| Ortin Laboratories Limited stock price | 19.9 INR |
| Previous Close | 24.5 INR |
| Open | 25.45 INR |
| Bid | 24.4 INR x N/A |
| Ask | 24.5 INR x N/A |
| Day's Range | 24.2 - 25.7 INR |
| 52 Week Range | 16.2 - 30.35 INR |
| Volume | 18.22K INR |
| Avg. Volume | 100.66K INR |
| Market Cap | 220.56M INR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.05 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ORTINLAB.NS Valuation Measures
| Enterprise Value | 255.99M INR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.6382136 |
| Price/Book (mrq) | 1.7973372 |
| Enterprise Value/Revenue | 4.223 |
| Enterprise Value/EBITDA | 45.492 |
Trading Information
Ortin Laboratories Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 8.64% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 30.35 INR |
| 52 Week Low | 16.2 INR |
| 50-Day Moving Average | 20.01 INR |
| 200-Day Moving Average | 22.3 INR |
ORTINLAB.NS Share Statistics
| Avg. Volume (3 month) | 100.66K INR |
| Avg. Daily Volume (10-Days) | 496.32K INR |
| Shares Outstanding | 8.13M |
| Float | 4.31M |
| Short Ratio | N/A |
| % Held by Insiders | 31.58% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 48:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -1.10% |
| Operating Margin (ttm) | 5.15% |
| Gross Margin | 44.08% |
| EBITDA Margin | 9.28% |
Management Effectiveness
| Return on Assets (ttm) | 0.93% |
| Return on Equity (ttm) | -0.61% |
Income Statement
| Revenue (ttm) | 60.62M INR |
| Revenue Per Share (ttm) | 7.25 INR |
| Quarterly Revenue Growth (yoy) | -35.50% |
| Gross Profit (ttm) | 26.73M INR |
| EBITDA | 5.63M INR |
| Net Income Avi to Common (ttm) | -669000 INR |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.56M INR |
| Total Cash Per Share (mrq) | 0.32 INR |
| Total Debt (mrq) | 64.47M INR |
| Total Debt/Equity (mrq) | 59.34 INR |
| Current Ratio (mrq) | 0.936 |
| Book Value Per Share (mrq) | 13.52 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2445000 INR |
| Levered Free Cash Flow (ttm) | -5262028 INR |
Profile of Ortin Laboratories Limited
| Country | India |
| State | N/A |
| City | Hyderabad |
| Address | D. No. 1-8-B4, |
| ZIP | 500044 |
| Phone | 91 40 2756 2055 |
| Website | https://www.ortinlabsindia.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, it offers active pharmaceutical ingredient (API) intermediates comprising anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, such as development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Q&A For Ortin Laboratories Limited Stock
What is a current ORTINLAB.NS stock price?
Ortin Laboratories Limited ORTINLAB.NS stock price today per share is 19.9 INR.
How to purchase Ortin Laboratories Limited stock?
You can buy ORTINLAB.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ortin Laboratories Limited?
The stock symbol or ticker of Ortin Laboratories Limited is ORTINLAB.NS.
Which industry does the Ortin Laboratories Limited company belong to?
The Ortin Laboratories Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Ortin Laboratories Limited have in circulation?
The max supply of Ortin Laboratories Limited shares is 8.16M.
What is Ortin Laboratories Limited Price to Earnings Ratio (PE Ratio)?
Ortin Laboratories Limited PE Ratio is now.
What was Ortin Laboratories Limited earnings per share over the trailing 12 months (TTM)?
Ortin Laboratories Limited EPS is -5.05 INR over the trailing 12 months.
Which sector does the Ortin Laboratories Limited company belong to?
The Ortin Laboratories Limited sector is Healthcare.